Navigation Links
Health Robotics Continues to Dominate I.V. Automation in America, With 11 New Contracts in Second Quarter 2010
Date:8/4/2010

BOZEN, SUD-TIROL, Italy, August 4, 2010 /PRNewswire/ -- Health Robotics announced its second consecutive quarter's record-breaking results, as reported by our sales channel partner Health Robotics Canada Inc. (HRCI) since Health Robotics S.r.l. upgraded its American distribution channels this year. HRCI's impressive results included new North American contracts for 4 i.v.STATION, 4 i.v.SOFT, and 3 I.V. Room of the Future projects, bringing Health Robotics' 2010 first semester total to 26 new American contracted installations, compared to 1 new contract announced by all of our direct competitors combined within the same 6-month period, and to zero contracts signed by our prior North American distribution channels during the entire 2009 year.

"We had an outstanding second consecutive quarter of operations in the USA and Canada including the first-ever American i.v.STATION contracts at a Pediatric hospital and an Outsourcing Pharmacy; the first worldwide contract for i.v.SOFT at a Pediatric hospital; and the first i.v.Room of the Future agreement at a regional hospital network (IDN). Combined with international results, we have now reached 105 contracted installations around the world. Due to the record demand for both i.v.STATION and i.v.SOFT, HRCI will close down this Summer its Early-Adopter discount programs for these two products, self-constraining future 3Q North American sales to five extra units (each) of i.v.STATION and i.v.SOFT Assist for installation in 4Q2010, with the remainder of future sales contracts to be scheduled for 2011 installation slots. We expect our upgraded North American sales channel partners to significantly add additional new contracted installations to the implementation backlog during 3Q2010" stated Werner Rainer, Health Robotics' CEO.

New contracts for installations of 4 i.v.STATION robots were signed by The Cleveland Clinic Foundation, Long Beach Memorial Hospital, Miller Children's Hospital, and finally Health Robotics' first I.V. Outsourcing customer: Pharmacie Linda Frayne & John DiGenova (Montreal). All of these robots are scheduled to "go-live" before the end of 2010, as Health Robotics has now achieved the ability to move to a standard and more streamlined implementation work-plan and schedule, made possible by the results and experience gathered by earlier i.v.STATION Beta Tests in Europe and the United States of America.

Additionally, Ochsner Clinic Foundation, Sutter Health-Sacramento Sierra Region, and USC University Hospital signed 3 new exclusive contracts for the I.V. Room of the Future, including their respective Chief Pharmacy Officers participation in Health Robotics' Scientific Advisory Board, where they will shortly join The Cleveland Clinic Foundation.

Finally, 4 new contracts for installations of i.v.SOFT Assist, Profile, and Label+ workflow software automation modules were executed by Children's Hospital of Los Angeles, Ochsner Clinic Foundation, U Mass Medical Center, and USC University Hospital. These new i.v.SOFT installations are to follow in 3Q2010 the already in-progress Beta-Tests installations announced last April for both Chemotherapy and for Non-Hazardous IVs, and to be completed over the next few months at Brigham & Women's Hospital, The Cleveland Clinic Foundation, Duke University Medical Center, University of Chicago Medical Center, and the University of Texas MD Anderson Cancer Center.

About Health Robotics:

Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing over 100 hospital installations in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [manual compounding software], MEDarchiver(TM) [life-critical clinical information system], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff.

    For more company information, please visit
http://www.health-robotics.com/en/about-health-robotics/.

    For additional information, please contact:
    Claudia Flaim, Marketing Coordinator
    flaim@health-robotics.com
    Phone: +39-0471-200-372


'/>"/>
SOURCE Health Robotics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... MOUNTAIN VIEW, Calif. , April 19, 2017 /PRNewswire/ ... that it will release financial results for the first ... May 3, 2017.  The Company,s management team will host ... / 5:30 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished ... the Outlier Leadership Series, Outliers in Writing, set to publish in summer 2017. ... Medicine at the University of Arizona College of Medicine. He also serves as Medical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):